Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Anticancer Drugs ; 28(8): 898-910, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28657910

RESUMO

The main aim of this study is to assess the safety and antitumor efficacy of a palladium(II) (Pd)-saccharinate complex with terpyridine. To characterize the Pd(II) complex in vitro, its cytotoxicity was evaluated using a water-soluble tetrazolium salt cell viability assay and the mechanism of cell death was assessed by DNA fragmentation/condensation and live cell imaging analyses. The antitumor efficacy and safety of the Pd(II) complex in-vivo were examined by analyzing reduction in tumor size, changes in body and organ weight, histopathological analysis of liver, kidney, and tumor sections, and biochemical analysis of serum in C57BL/6 mice. Our results showed that the Pd(II) complex was more cytotoxic to cancer cells than noncancer cell lines and caused cell death through apoptotic pathways. The treatment of the Pd(II) complex in tumor-bearing mice effectively reduced the tumor size at half the dose used for cisplatin. The Pd(II) complex appeared to exert less liver damage than the cisplatin-based complex on changes in the hepatic enzymes levels in the serum. Hence, the complex appears to be a potential chemotherapeutic drug with high antitumor efficacy and fewer hepatotoxic complications, providing an avenue for further studies.


Assuntos
Antineoplásicos/química , Antineoplásicos/farmacologia , Cisplatino/farmacologia , Complexos de Coordenação/química , Complexos de Coordenação/farmacologia , Neoplasias/tratamento farmacológico , Células A549 , Aloenxertos , Animais , Antineoplásicos/sangue , Antineoplásicos/toxicidade , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Cisplatino/sangue , Cisplatino/toxicidade , Complexos de Coordenação/sangue , Complexos de Coordenação/toxicidade , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Células HeLa , Humanos , Fígado/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Transplante de Neoplasias , Neoplasias/sangue
2.
J Craniofac Surg ; 27(1): 253-7, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26703066

RESUMO

Because of limited autogenous tissue sources, donor site morbidity, and difficulty of shaping the autologous tissue, surgeons often need to use alloplastic frameworks in reconstruction of 3-dimensional tissue defects. Synthetic porous polyethylene (PP) implant is widely used in plastic surgery for 3-dimensional reconstruction of the lost or highly deformed tissues. One of the main factors of PP implant exposure is delayed fibrovascular ingrowth. In the present study, the authors investigated the effect allogeneic plateletlysate (PL) and cyanoacrylate tissue glue (CTG) (2-octyl cyanoacrylate) on the fibrovascularization of the PP implant.Twenty adult female Wistar rats were divided into 4 groups equally, according to the different surgical techniques and implanted materials used. Only PP implant was implanted subcutaneously through a skin incision on the chest wall skin of the rats in the control group; however, CTG was applied with PP implant in the cyanoacrylate group, PL was applied with PP implant in the platelet group, CTG and platelet was applied together with PP implant in the combination group. All of the implants in each group were histologically assessed at postoperative second week. Determination of the collagen density in the tissues, inflammation, and necrosis and vascularization status was assessed semiquantitatively.A denser collagen structure, low inflammation, and necrosis were found in PL groups. There was, however, a significant decrease in vascular density with PL-treated groups. PL treatment may have a potential to reduce complications related to PP implants.


Assuntos
Aloenxertos/transplante , Cianoacrilatos/uso terapêutico , Implantes Experimentais , Plasma Rico em Plaquetas/fisiologia , Polietileno/química , Tela Subcutânea/cirurgia , Adesivos Teciduais/uso terapêutico , Animais , Plaquetas/fisiologia , Colágeno/análise , Tecido Conjuntivo/patologia , Feminino , Inflamação , Necrose , Neovascularização Fisiológica/fisiologia , Porosidade , Ratos , Ratos Wistar
3.
J Exp Zool A Ecol Genet Physiol ; 309(5): 255-61, 2008 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-18366101

RESUMO

In this study, the presence of antifreeze protein (AFP) gene expression through successive generations in transgenic mice carrying the chimeric gene construct of the coding sequence for the AFP protein from ocean pout was investigated. AFP transgenic hemizygote mice were used for AFP gene expression. AFP genome expressions in transgenic mice were analyzed by Western blotting, and tissue location of AFP protein was shown by immunohistochemical and immunofluorescence techniques. Seventh transgenic mice from the established founders demonstrated the expression of AFP in organs such as the skin, oviduct, lung, kidney and liver tissues and serum except for the heart. Our results demonstrate successful expression of AFP gene products in several tissues and serum of transgenic mice, the association of in vivo expressed AFP protein, for the first time. These results indicate that the coding sequence for the AFP protein gene (ocean pout type III AFP gene) could be integrated and stably transcribed and expressed in the 7th generation of transgenic mice. In conclusion transgenic mouse lines would be a good model for the cryostudy of AFP and for the determination of AFP roles in several organs and tissues.


Assuntos
Proteínas Anticongelantes Tipo III/metabolismo , Rim/metabolismo , Fígado/metabolismo , Pulmão/metabolismo , Oviductos/metabolismo , Pele/metabolismo , Animais , Proteínas Anticongelantes Tipo III/genética , Feminino , Peixes , Camundongos , Camundongos Transgênicos , Modelos Animais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA